|
| | Publication Year | Title | Author(s) |
| 101 | Jun-2023 | Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future. | Gan, Hui Kong ; Day, Bryan W; Harrup, Rosemary; Johns, Terrance G; Lwin, Zarnie; Scott, Andrew Mark; Sim, Hao-Wen; Koh, Eng-Siew |
| 102 | 1-Jun-2008 | Clinicians' attitudes towards management of metastatic colorectal adenocarcinoma. | Wong, Rachel; Wiley, Malcolm; Christophi, Christopher ; Tebbutt, Niall C |
| 103 | Nov-2018 | Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database. | Salem, Mohamed E; Yin, Jun; Weinberg, Benjamin A; Renfro, Lindsay A; Pederson, Levi D; Maughan, Timothy S; Adams, Richard A; Van Cutsem, Eric; Falcone, Alfredo; Tebbutt, Niall C ; Seymour, Matthew T; Díaz-Rubio, Eduardo; Aranda, Enrique; Bokemeyer, Carsten; Heinemann, Volker; Wasan, Harpreet; de Gramont, Aimery; Grothey, Axel; Shi, Qian; Sargent, Daniel J; Marshall, John L |
| 104 | Oct-2021 | Colorimetric histology using plasmonically active microscope slides. | Balaur, Eugeniu; O' Toole, Sandra; Spurling, Alex J; Mann, G Bruce; Yeo, Belinda ; Harvey, Kate; Sadatnajafi, Catherine; Hanssen, Eric; Orian, Jacqueline; Nugent, Keith A; Parker, Belinda S; Abbey, Brian |
| 105 | 12-Apr-2021 | Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538. | Klein, Oliver ; Senko, Clare ; Carlino, Matteo S; Markman, Ben; Jackett, Louise A ; Gao, Bo; Lum, Caroline; Kee, Damien ; Behren, Andreas; Palmer, Jodie ; Cebon, Jonathan S |
| 106 | Nov-2021 | Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial. | Klein, Oliver ; Kee, Damien ; Gao, Bo; Markman, Ben; da Gama Duarte, Jessica; Quigley, Luke; Jackett, Louise A ; Linklater, Richelle; Strickland, Andrew; Scott, Clare; Mileshkin, Linda; Palmer, Jodie ; Carlino, Matteo; Behren, Andreas; Cebon, Jonathan S |
| 107 | Nov-2017 | Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung Cancer. | Arulananda, Surein; Do, Hongdo; Musafer, Ashan; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas |
| 108 | Jul-2016 | Combined BRAF and MEK inhibition in BRAF-mutant NSCLC. | Rivalland, Gareth; Mitchell, Paul L R |
| 109 | 5-Apr-2019 | Combined tumor sequencing and case/control analyses of RAD51C in breast cancer. | Li, Na; McInerny, Simone; Zethoven, Magnus; Cheasley, Dane; Lim, Belle W X; Rowley, Simone M; Devereux, Lisa; Grewal, Norah; Ahmadloo, Somayeh; Byrne, David; Lee, Jue Er Amanda; Li, Jason; Fox, Stephen B; John, Thomas ; Antill, Yoland; Gorringe, Kylie L; James, Paul A; Campbell, Ian G |
| 110 | 1-Apr-2011 | Comment on "A report of the natural history of leptomeningeal gliomatosis". | Cher, Lawrence M |
| 111 | 26-Sep-2012 | Commentary: extensive cortical involvement in leptomeningeal carcinomatosis. | Cher, Lawrence M |
| 112 | Oct-2018 | Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial. | Field, Kathryn M; Fitt, Gregory J ; Rosenthal, Mark A; Simes, John; Nowak, Anna K; Barnes, Elizabeth H; Sawkins, Kate; Goh, Christine; Moffat, Bradford A; Salinas, Simon; Cher, Lawrence M ; Wheeler, Helen; Hovey, Elizabeth J; Phal, Pramit M |
| 113 | 1-Jun-2019 | Comparison of Biomarker Assays for EGFR: Implications for Precision Medicine in Patients with Glioblastoma. | Lassman, Andrew B; Roberts-Rapp, Lisa A; Sokolova, Irina; Song, Minghao; Pestova, Ekaterina; Kular, Rupinder; Mullen, Carolyn; Zha, Zheng; Lu, Xin; Gomez, Erica; Bhathena, Anahita; Maag, David; Kumthekar, Priya; Gan, Hui K ; Scott, Andrew M ; Guseva, Maria; Holen, Kyle D; Ansell, Peter; van den Bent, Martin J |
| 114 | 16-Oct-2013 | Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer. | Liew, Mun Sem; Sia, Joseph; Starmans, Maud H W; Tafreshi, Ali; Harris, Sam; Feigen, Malcolm; White, Shane C; Zimet, Allan; Lambin, Philippe; Boutros, Paul C; Mitchell, Paul L R ; John, Thomas |
| 115 | 16-May-1992 | Comparison of transcranial Doppler with DSA in vertebrobasilar ischaemia. | Cher, Lawrence M ; Chambers, Brian R ; Smidt, V |
| 116 | Dec-2020 | Complete response of metastatic pleomorphic dermal sarcoma to anti-PD-1 therapy. | Klein, Oliver ; McTigue, C; Wong, Z W; Syme, D B; Hunter-Smith, D J |
| 117 | 13-May-2022 | Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin. | Berthelet, Jean; Foroutan, Momeneh; Bhuva, Dharmesh D; Whitfield, Holly J; El-Saafin, Farrah; Cursons, Joseph; Serrano, Antonin; Merdas, Michal; Lim, Elgene; Charafe-Jauffret, Emmanuelle; Ginestier, Christophe; Ernst, Matthias ; Hollande, Frédéric; Anderson, Robin L ; Pal, Bhupinder; Yeo, Belinda ; Davis, Melissa J; Merino, Delphine |
| 118 | 2022 | Consolidation nivolumab and ipilimumab versus observation in limited-disease small cell lung cancer after chemo-radiotherapy - Results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial. | Peters, S ; Pujol, J-L; Dafni, U; Dómine, M; Popat, S; Reck, M; Andrade, J; Becker, A; Moro-Sibilot, D; Curioni-Fontecedro, A; Molinier, O; Nackaerts, K; Mollá, A Insa; Gervais, R; Vivanco, G López; Madelaine, J; Mazieres, J; Faehling, M; Griesinger, F; Majem, M; Larriba, J L González; Pulla, M Provencio; Vervita, K; Roschitzki-Voser, H; Ruepp, B; Mitchell, Paul L R ; Stahel, R A; Le Pechoux, C; De Ruysscher, D |
| 19 | 11-Oct-2018 | Correction to: Differences in cancer survival by sex: a population-based study using cancer registry data. | Afshar, Nina; English, Dallas R; Thursfield, Vicky; Mitchell, Paul L R ; Te Marvelde, Luc; Farrugia, Helen; Giles, Graham G; Milne, Roger L |
| 20 | 8-Sep-2021 | Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants. | Murali, Krithika; Dwarte, Tanya M; Nikfarjam, Mehrdad ; Tucker, Katherine M; Vaughan, Rhys B ; Efthymiou, Marios ; Collins, Allison L ; Spigelman, Allan D; Salmon, Lucinda ; Johns, Amber L; Williams, David B; Delatycki, Martin B ; John, Thomas ; Stoita, Alina |
